The spindle assembly checkpoint: perspectives in tumorigenesis and cancer therapy

Aguilera A, Gómez-González B (2008). Genome instability: a mechanistic view of its causes and consequences. Nat Rev Genet, 9(3): 204–217 Ando K, Kakeji Y, Kitao H, Iimori M, Zhao Y, Yoshida R, Oki E, Yoshinaga K, Matumoto T, Morita M, Sakaguchi Y, Maehara Y (2010). High expression of BUBR1 is one of the factors for inducing DNA aneuploidy and progression in gastric cancer. Cancer Sci, 101(3): 639–645 Bagasra O, Prilliman K R (2004). RNA interference: the molecular immune system. J Mol Histol, 35(6): 545–553 Bakhoum S F, Genovese G, Compton D A (2009). Deviant kinetochore microtubule dynamics underlie chromosomal instability. Curr Biol, 19(22): 1937–1942 Bannon J H, Mc Gee M M (2009). Understanding the role of aneuploidy in tumorigenesis. Biochem Soc Trans, 37(Pt 4): 910–913 Basu J, Bousbaa H, Logarinho E, Li Z, Williams B C, Lopes C, Sunkel C E, Goldberg M L (1999). Mutations in the essential spindle checkpoint gene bub1 cause chromosome missegregation and fail to block apoptosis in Drosophila. J Cell Biol, 146(1): 13–28 Basu J, Logarinho E, Herrmann S, Bousbaa H, Li Z, Chan G K, Yen T J, Sunkel C E, Goldberg M L (1998). Localization of the Drosophila checkpoint control protein Bub3 to the kinetochore requires Bub1 but not Zw10 or Rod. Chromosoma, 107(6–7): 376–385 Bharadwaj R, Yu H (2004). The spindle checkpoint, aneuploidy, and cancer. Oncogene, 23(11): 2016–2027 Bolanos-Garcia VM (2009). Assessment of the mitotic spindle assembly checkpoint (SAC) as the target of anticancer therapies. Curr Cancer Drug Targets, 9(2): 131–141 Burum-Auensen E, DeAngelis PM, Schjølberg A R, Røislien J, Mjåland O, Clausen O P (2008). Reduced level of the spindle checkpoint protein BUB1B is associated with aneuploidy in colorectal cancers. Cell Prolif, 41(4): 645–659 Cahill D P, da Costa L T, Carson-Walter E B, Kinzler KW, Vogelstein B, Lengauer C (1999). Characterization of MAD2B and other mitotic spindle checkpoint genes. Genomics, 58(2): 181–187 Cheeseman I M, Desai A (2008). Molecular architecture of the kinetochore-microtubule interface. Nat Rev Mol Cell Biol, 9(1):33–46 Chi Y H, Jeang K T (2007). Aneuploidy and cancer. J Cell Biochem, 102(3): 531–538 Clarke D J, Giménez-Abián J F (2000). Checkpoints controlling mitosis. Bioessays, 22(4): 351–363 Dai W, Wang Q, Liu T, Swamy M, Fang Y, Xie S, Mahmood R, Yang Y M, Xu M, Rao C V (2004). Slippage of mitotic arrest and enhanced tumor development in mice with BubR1 haploinsufficiency. Cancer Res, 64(2): 440–445 Dalton W B, Yang V W (2009). Role of prolonged mitotic checkpoint activation in the formation and treatment of cancer. Future Oncol, 5(9): 1363–1370 Dobles M, Liberal V, Scott M L, Benezra R, Sorger P K (2000). Chromosome missegregation and apoptosis in mice lacking the mitotic checkpoint protein Mad2. Cell, 101(6): 635–645 Earnshaw W C, Mackay A M (1994). Role of nonhistone proteins in the chromosomal events of mitosis. FASEB J, 8(12): 947–956 Fung M K, Cheung H W, Wong H L, Yuen H F, Ling M T, Chan K W, Wong Y C, Cheung A L, Wang X (2007). MAD2 expression and its significance in mitotic checkpoint control in testicular germ cell tumour. Biochim Biophys Acta, 1773(6): 821–832 Ganem N J, Godinho S A, Pellman D (2009). A mechanism linking extra centrosomes to chromosomal instability. Nature, 460(7252): 278–282 Gemma A, Hosoya Y, Seike M, Uematsu K, Kurimoto F, Hibino S, Yoshimura A, Shibuya M, Kudoh S, Emi M (2001). Genomic structure of the human MAD2 gene and mutation analysis in human lung and breast cancers. Lung Cancer, 32(3): 289–295 Gemma A, Seike M, Seike Y, Uematsu K, Hibino S, Kurimoto F, Yoshimura A, Shibuya M, Harris C C, Kudoh S (2000). Somatic mutation of the hBUB1 mitotic checkpoint gene in primary lung cancer. Genes Chromosomes Cancer, 29(3): 213–218 Grabsch H I, Askham J M, Morrison E E, Pomjanski N, Lickvers K, Parsons W J, Boecking A, Gabbert H E, Mueller W (2004). Expression of BUB1 protein in gastric cancer correlates with the histological subtype, but not with DNA ploidy or microsatellite instability. J Pathol, 202(2): 208–214 Green R A, Kaplan K B (2003). Chromosome instability in colorectal tumor cells is associated with defects in microtubule plus-end attachments caused by a dominant mutation in APC. J Cell Biol, 163(5): 949–961 Haruki N, Saito H, Harano T, Nomoto S, Takahashi T, Osada H, Fujii Y, Takahashi T (2001). Molecular analysis of the mitotic checkpoint genes BUB1, BUBR1 and BUB3 in human lung cancers. Cancer Lett, 162(2): 201–205 Hernando E, Orlow I, Liberal V, Nohales G, Benezra R, Cordon-Cardo C (2001). Molecular analyses of the mitotic checkpoint components hsMAD2, hBUB1 and hBUB3 in human cancer. Int J Cancer, 95(4): 223–227 Howell B J, McEwen B F, Canman J C, Hoffman D B, Farrar E M, Rieder C L, Salmon E D (2001). Cytoplasmic dynein/dynactin drives kinetochore protein transport to the spindle poles and has a role in mitotic spindle checkpoint inactivation. J Cell Biol, 155(7): 1159–1172 Hoyt M A, Totis L, Roberts B T (1991). S. cerevisiae genes required for cell cycle arrest in response to loss of microtubule function. Cell, 66(3): 507–517 Imai Y, Shiratori Y, Kato N, Inoue T, Omata M (1999). Mutational inactivation of mitotic checkpoint genes, hsMAD2 and hBUB1, is rare in sporadic digestive tract cancers. Jpn J Cancer Res, 90(8): 837–840 Jeganathan K, Malureanu L, Baker D J, Abraham S C, van Deursen J M (2007). Bub1 mediates cell death in response to chromosome missegregation and acts to suppress spontaneous tumorigenesis. J Cell Biol, 179(2): 255–267 Ji A M, Su D, Che O, Li W S, Sun L, Zhang Z Y, Yang B, Xu F (2009). Functional gene silencing mediated by chitosan/siRNA nanocomplexes. Nanotechnology, 20(40): 405103 Jordan M A, Wilson L (2004). Microtubules as a target for anticancer drugs. Nat Rev Cancer, 4(4): 253–265 Kalitsis P, Fowler K J, Griffiths B, Earle E, Chow CW, Jamsen K, Choo K H (2005). Increased chromosome instability but not cancer predisposition in haploinsufficient Bub3 mice. Genes Chromosomes Cancer, 44(1): 29–36 Kienitz A, Vogel C, Morales I, Müller R, Bastians H (2005). Partial downregulation of MAD1 causes spindle checkpoint inactivation and aneuploidy, but does not confer resistance towards taxol. Oncogene, 24(26): 4301–4310 Ko Y H, Roh J H, Son Y I, Chung M K, Jang J Y, Byun H, Baek C H, Jeong H S (2010). Expression of mitotic checkpoint proteins BUB1B and MAD2L1 in salivary duct carcinomas. J Oral Pathol Med, 39(4): 349–355 Kops G J (2009). Dividing the goods: co-ordination of chromosome biorientation and mitotic checkpoint signalling by mitotic kinases. Biochem Soc Trans, 37(Pt 5): 971–975 Kops G J, Foltz D R, Cleveland D W (2004). Lethality to human cancercells through massive chromosome loss by inhibition of the mitotic checkpoint. Proc Natl Acad Sci USA, 101(23): 8699–8704 Kops G J, Weaver B A, Cleveland D W (2005). On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer, 5(10): 773–785 Lin S F, Lin P M, Yang M C, Liu T C, Chang J G, Sue Y C, Chen T P (2002). Expression of hBUB1 in acute myeloid leukemia. Leuk Lymphoma, 43(2): 385–391 Logarinho E, Bousbaa H (2008). Kinetochore-microtubule interactions “in check” by Bub1, Bub3 and BubR1: The dual task of attaching and signalling. Cell Cycle, 7(12): 1763–176 Masuda A, Maeno K, Nakagawa T, Saito H, Takahashi T (2003). Association between mitotic spindle checkpoint impairment and susceptibility to the induction of apoptosis by anti-microtubule agents in human lung cancers. Am J Pathol, 163(3): 1109–1116 Michel L, Diaz-Rodriguez E, Narayan G, Hernando E, Murty V V, Benezra R (2004). Complete loss of the tumor suppressor MAD2 causes premature cyclin B degradation and mitotic failure in human somatic cells. Proc Natl Acad Sci USA, 101(13): 4459–4464 Mimori K, Inoue H, Alder H, Ueo H, Tanaka Y, Mori M (2001). Mutation analysis of hBUB1, human mitotic checkpoint gene in multiple carcinomas. Oncol Rep, 8(1): 39–42 Minhas K M, Singh B, Jiang W W, Sidransky D, Califano J A (2003). Spindle assembly checkpoint defects and chromosomal instability in head and neck squamous cell carcinoma. Int J Cancer, 107(1): 46–52 Mondal G, Sengupta S, Panda C K, Gollin S M, Saunders W S, Roychoudhury S (2007). Overexpression of Cdc20 leads to impairment of the spindle assembly checkpoint and aneuploidization in oral cancer. Carcinogenesis, 28(1): 81–92 Morgan D O (1999). Regulation of the APC and the exit from mitosis. Nat Cell Biol, 1(2): E47–E53 Musacchio A, Salmon E D (2007). The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol, 8(5): 379–393 Myrie K A, Percy M J, Azim J N, Neeley C K, Petty E M (2000). Mutation and expression analysis of human BUB1 and BUB1B in aneuploid breast cancer cell lines. Cancer Lett, 152(2): 193–199 Nasmyth K (2005). How do so few control so many? Cell, 120(6): 739–746 Niikura Y, Dixit A, Scott R, Perkins G, Kitagawa K (2007). BUB1 mediation of caspase-independent mitotic death determines cell fate. J Cell Biol, 178(2): 283–296 Ohshima K, Haraoka S, Yoshioka S, Hamasaki M, Fujiki T, Suzumiya J, Kawasaki C, Kanda M, Kikuchi M (2000). Mutation analysis of mitotic checkpoint genes (hBUB1 and hBUBR1) and microsatellite instability in adult T-cell leukemia/lymphoma. Cancer Lett, 158(2): 141–150 Olesen S H, Thykjaer T, Ørntoft T F (2001). Mitotic checkpoint genes hBUB1, hBUB1B, hBUB3 and TTK in human bladder cancer, screening for mutations and loss of heterozygosity. Carcinogenesis, 22(5): 813–815 Orr B, Bousbaa H, Sunkel C E (2007). Mad2-independent spindle assembly checkpoint activation and controlled metaphase-anaphase transition in Drosophila S2 cells. Mol Biol Cell, 18(3): 850–863 Ouyang B, Knauf J A, Ain K, Nacev B, Fagin J A (2002). Mechanisms of aneuploidy in thyroid cancer cell lines and tissues: evidence for mitotic checkpoint dysfunction without mutations in BUB1 and BUBR1. Clin Endocrinol (Oxf), 56(3): 341–350 Pan C, Yan M, Yao J, Xu J, Long Z, Huang H, Liu Q (2008). Aurora kinase small molecule inhibitor destroys mitotic spindle, suppresses cell growth, and induces apoptosis in oral squamous cancer cells. Oral Oncol, 44(7): 639–645 Percy M J, Myrie K A, Neeley C K, Azim J N, Ethier S P, Petty E M (2000). Expression and mutational analyses of the human MAD2L1 gene in breast cancer cells. Genes Chromosomes Cancer, 29(4): 356–362 Pinto M, Soares M J, Cerveira N, Henrique R, Ribeiro F R, Oliveira J, Jerónimo C, Teixeira M R (2007). Expression changes of the MAD mitotic checkpoint gene family in renal cell carcinomas characterized by numerical chromosome changes. Virchows Arch, 450(4): 379–385 Pinto M, Vieira J, Ribeiro F R, Soares M J, Henrique R, Oliveira J, Jerónimo C, Teixeira M R (2008). Overexpression of the mitotic checkpoint genes BUB1 and BUBR1 is associated with genomic complexity in clear cell kidney carcinomas. Cell Oncol, 30(5): 389–395 Przewloka M R, Glover D M (2009). The kinetochore and the centromere: a working long distance relationship. Annu Rev Genet, 43(1): 439–465 Reddy S K, Rape M, Margansky W A, Kirschner M W (2007). Ubiquitination by the anaphase-promoting complex drives spindle checkpoint inactivation. Nature, 446(7138): 921–925 Reis R M, Nakamura M, Masuoka J, Watanabe T, Colella S, Yonekawa Y, Kleihues P, Ohgaki H (2001). Mutation analysis of hBUB1, hBUBR1 and hBUB3 genes in glioblastomas. Acta Neuropathol, 101(4): 297–304 Rimkus C, Friederichs J, Rosenberg R, Holzmann B, Siewert J R, Janssen K P (2007). Expression of the mitotic checkpoint gene MAD2L2 has prognostic significance in colon cancer. Int J Cancer, 120(1): 207–211 Roberts B T, Farr K A, Hoyt MA (1994). The Saccharomyces cerevisiae checkpoint gene BUB1 encodes a novel protein kinase. Mol Cell Biol, 14(12): 8282–8291 Saeki A, Tamura S, Ito N, Kiso S, Matsuda Y, Yabuuchi I, Kawata S, Matsuzawa Y (2002). Frequent impairment of the spindle assembly checkpoint in hepatocellular carcinoma. Cancer, 94(7): 2047–2054 Satchi-Fainaro R, Duncan R (2006) Advances in Polymer Science Polymer Therapeutics I: Springer. Sato M, Sekido Y, Horio Y, Takahashi M, Saito H, Minna J D, Shimokata K, Hasegawa Y (2000). Infrequent mutation of the hBUB1 and hBUBR1 genes in human lung cancer. Jpn J Cancer Res, 91(5): 504–509 Scannevin R H, Wang K, Jow F, Megules J, Kopsco D C, Edris W, Carroll K C, Lü Q, Xu W, Xu Z, Katz A H, Olland S, Lin L, Taylor M, Stahl M, Malakian K, Somers W, Mosyak L, Bowlby M R, Chanda P, Rhodes K J (2004). Two N-terminal domains of Kv4 K(+) channels regulate binding to and modulation by KChIP1. Neuron, 41(4): 587–598 Schafer K A (1998). The cell cycle: a review. Vet Pathol, 35(6): 461–478 Schmidt M, Medema R H (2006). Exploiting the compromised spindle assembly checkpoint function of tumor cells: dawn on the horizon? Cell Cycle, 5(2): 159–163 Screpanti E, Santaguida S, Nguyen T, Silvestri R, Gussio R, Musacchio A, Hamel E, DeWulf P (2010). A screen for kinetochore-microtubule interaction inhibitors identifies novel antitubulin compounds. PLoS ONE, 5(7): e11603 Seike M, Gemma A, Hosoya Y, Hosomi Y, Okano T, Kurimoto F, Uematsu K, Takenaka K, Yoshimura A, Shibuya M, Ui-Tei K, Kudoh S (2002). The promoter region of the human BUBR1 gene and its expression analysis in lung cancer. Lung Cancer, 38(3): 229–234 Shi Q, Hu M, Luo M, Liu Q, Jiang F, Zhang Y, Wang S, Yan C, Weng Y (2010) Reduced expression of Mad2 and Bub1 proteins is associated with spontaneous abortions. Mol Hum Reprod Shigeishi H, Oue N, Kuniyasu H, Wakikawa A, Yokozaki H, Ishikawa T, Yasui W (2001a). Expression of Bub1 gene correlates with tumor proliferating activity in human gastric carcinomas. Pathobiology, 69(1): 24–29 Shigeishi H, Yokozaki H, Kuniyasu H, Nakagawa H, Ishikawa T, Tahara E, Yasui W (2001b). No mutations of the Bub1 gene in human gastric carcinomas. Oncol Rep, 8(4): 791–794 Silkworth W T, Nardi I K, Scholl L M, Cimini D (2009). Multipolar spindle pole coalescence is a major source of kinetochore misattachment and chromosome mis-segregation in cancer cells. PLoS ONE, 4(8): e6564 Stegmeier F, Rape M, Draviam V M, Nalepa G, Sowa M E, Ang X L, McDonald E R 3rd, Li M Z, Hannon G J, Sorger P K, Kirschner M W, Harper J W, Elledge S J (2007). Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities. Nature, 446(7138): 876–881 Sudakin V, Chan G K, Yen T J (2001). Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2. J Cell Biol, 154(5): 925–936 Suijkerbuijk S J, Kops G J (2008). Preventing aneuploidy: the contribution of mitotic checkpoint proteins. Biochim Biophys Acta, 1786(1): 24–31 Sze K M, Ching Y P, Jin D Y, Ng I O (2004). Association of MAD2 expression with mitotic checkpoint competence in hepatoma cells. J Biomed Sci, 11(6): 920–927 Takahashi T, Haruki N, Nomoto S, Masuda A, Saji S, Osada H, Takahashi T (1999). Identification of frequent impairment of the mitotic checkpoint and molecular analysis of the mitotic checkpoint genes, hsMAD2 and p55CDC, in human lung cancers. Oncogene, 18(30): 4295–4300 Tanaka K, Mohri Y, Ohi M, Yokoe T, Koike Y, Morimoto Y, Miki C, Tonouchi H, Kusunoki M (2008). Mitotic checkpoint genes, hsMAD2 and BubR1, in oesophageal squamous cancer cells and their association with 5-fluorouracil and cisplatin-based radiochemotherapy. Clin Oncol (R Coll Radiol), 20(8): 639–646 Tsukasaki K, Miller C W, Greenspun E, Eshaghian S, Kawabata H, Fujimoto T, Tomonaga M, Sawyers C, Said JW, Koeffler H P (2001). Mutations in the mitotic check point gene, MAD1L1, in human cancers. Oncogene, 20(25): 3301–3305 Tyson J J, Novak B (2008). Temporal organization of the cell cycle. Curr Biol, 18(17): R759–R768 Wada N, Yoshida A, Miyagi Y, Yamamoto T, Nakayama H, Suganuma N, Matsuzu K, Masudo K, Hirakawa S, Rino Y, Masuda M, Imada T (2008). Overexpression of the mitotic spindle assembly checkpoint genes hBUB1, hBUBR1 and hMAD2 in thyroid carcinomas with aggressive nature. Anticancer Res, 28(1A): 139–144 Wang L, Yin F, Du Y, Chen B, Liang S, Zhang Y, Du W, Wu K, Ding J, Fan D (2010). Depression of MAD2 inhibits apoptosis and increases proliferation and multidrug resistance in gastric cancer cells by regulating the activation of phosphorylated survivin. Tumour Biol, 31(3): 225–232 Wang Z M, Lin H K, Zhu S R, Liu T F, Zhou Z F, Chen Y T (2000). Synthesis, characterization and cytotoxicity of lanthanum(III) complexes with novel 1,10-phenanthroline-2,9-bis-alpha-amino acid conjugates. Anticancer Drug Des, 15(6): 405–411 Weaver B A, Silk A D, Montagna C, Verdier-Pinard P, Cleveland D W (2007). Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell, 11(1): 25–36 Weitzel D H, Vandré D D (2000). Differential spindle assembly checkpoint response in human lung adenocarcinoma cells. Cell Tissue Res, 300(1): 57–65 Yamaguchi K, Okami K, Hibi K, Wehage S L, Jen J, Sidransky D (1999). Mutation analysis of hBUB1 in aneuploid HNSCC and lung cancer cell lines. Cancer Lett, 139(2): 183–187 Yoon D S, Wersto R P, Zhou W, Chrest F J, Garrett E S, Kwon T K, Gabrielson E (2002). Variable levels of chromosomal instability and mitotic spindle checkpoint defects in breast cancer. Am J Pathol, 161(2): 391–397 Zeng X, Sigoillot F, Gaur S, Choi S, Pfaff K L, Oh D C, Hathaway N, Dimova N, Cuny G D, King R W (2010). Pharmacologic inhibition of the anaphase-promoting complex induces a spindle checkpoint-dependent mitotic arrest in the absence of spindle damage. Cancer Cell, 18(4): 382–395